Cargando…

Systems biology in inflammatory bowel diseases: on the way to precision medicine

Inflammatory bowel diseases (IBD) are chronic and recurrent inflammatory disorders of the gastrointestinal tract. The elucidation of their etiopathology requires complex and multiple approaches. Systems biology has come to fulfill this need in approaching the pathogenetic mechanisms of IBD and its e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dovrolis, Nikolas, Filidou, Eirini, Kolios, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479645/ https://www.ncbi.nlm.nih.gov/pubmed/31040620 http://dx.doi.org/10.20524/aog.2019.0373

Ejemplares similares

Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”
por: Filidou, Eirini, et al.
Publicado: (2023)

Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
por: Dovrolis, Nikolas, et al.
Publicado: (2022)

Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: a systems bioinformatics approach
por: Gazouli, Maria, et al.
Publicado: (2019)

Probiotics in Intestinal Mucosal Healing: A New Therapy or an Old Friend?
por: Filidou, Eirini, et al.
Publicado: (2021)

The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases
por: Dovrolis, Nikolas, et al.
Publicado: (2020)

Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface
por: Valatas, Vassilis, et al.
Publicado: (2017)

Precision Medicine in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2023)

Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies
por: Cheah, Eric, et al.
Publicado: (2023)

The Length of Surgical Skin Incision in Postoperative Inflammatory Reaction
por: Ioannidis, Aristidis, et al.
Publicado: (2018)

Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease
por: Thomas, John P, et al.
Publicado: (2021)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter
por: Dovrolis, Nikolas, et al.
Publicado: (2023)

Precision medicine and drug optimization in adult inflammatory bowel disease patients
por: Vieujean, Sophie, et al.
Publicado: (2023)

Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease
por: Chuong, Kim H., et al.
Publicado: (2018)

Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells
por: Filidou, Eirini, et al.
Publicado: (2022)

Beyond the Rhythm: In Silico Identification of Key Genes and Therapeutic Targets in Atrial Fibrillation
por: Atzemian, Natalia, et al.
Publicado: (2023)

Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
por: Portokallidou, Konstantina, et al.
Publicado: (2023)

Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Multi-omics profiling: the way toward precision medicine in metabolic diseases
por: Hu, Cheng, et al.
Publicado: (2021)

Unlocking the Memory Component of Alzheimer’s Disease: Biological Processes and Pathways across Brain Regions
por: Dovrolis, Nikolas, et al.
Publicado: (2022)

Fecal Fungal Microbiota (Mycobiome) Study as a Potential Tool for Precision Medicine in Inflammatory Bowel Disease
por: Balderramo, Domingo C., et al.
Publicado: (2023)

Precision Medicine to Treat Urothelial Carcinoma—The Way Forward
por: Luceno, Carvy Floyd, et al.
Publicado: (2023)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

The microbiome in precision medicine: the way forward
por: Petrosino, Joseph F.
Publicado: (2018)

Precision Medicine: Changing the way we think about healthcare
por: Gameiro, Gustavo Rosa, et al.
Publicado: (2018)

Susceptibility gene profiling elucidates the pathogenesis of inflammatory bowel disease and provides precision medicine
por: Gao, Han, et al.
Publicado: (2023)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
por: Gao, Caifang, et al.
Publicado: (2019)

Biologic Concentration Testing in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2015)

Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine
por: Giachero, Federica, et al.
Publicado: (2021)

Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review
por: Koutouratsas, Tilemachos, et al.
Publicado: (2021)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
por: Katsanos, Konstantinos H., et al.
Publicado: (2017)

Is there an optimal sequence of biologic therapies for inflammatory bowel disease?
por: Bressler, Brian
Publicado: (2023)

Relationship between the Biological Clock and Inflammatory Bowel Disease
por: Giebfried, Jonathan, et al.
Publicado: (2023)

Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease
por: Wang, Liucan, et al.
Publicado: (2021)

Inflammatory bowel disease: towards a personalized medicine
por: Flamant, Mathurin, et al.
Publicado: (2018)

Amniotic Fluid-Derived Mesenchymal Stem/Stromal Cell-Derived Secretome and Exosomes Improve Inflammation in Human Intestinal Subepithelial Myofibroblasts
por: Katifelis, Hector, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h62ntl0hbk1shuu8f1hngmn8e4